Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Babbs RK"'
Autor:
Borrelli KN; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Graduate Program for Neuroscience, Boston University, Boston, Massachusetts 02118.; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.; NIGMS Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118., Yao EJ; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Yen WW; Neurobiology Section, Department of Biology, Boston University, Boston, Massachusetts 02215., Phadke RA; Neurobiology Section, Department of Biology, Boston University, Boston, Massachusetts 02215.; Molecular Biology, Cell Biology, and Biochemistry (MCBB), Boston University, Boston, Massachusetts 02215., Ruan QT; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.; NIGMS Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118., Chen MM; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Kelliher JC; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Langan CR; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Scotellaro JL; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Undergraduate Research Opportunity Program, Boston University, Boston, Massachusetts 02118., Babbs RK; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Beierle JC; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.; NIGMS Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118., Logan RW; Laboratory of Sleep, Rhythms, and Addiction, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.; Center for Systems Neurogenetics of Addiction, The Jackson Laboratory, Bar Harbor, Maine 04609., Johnson WE; Department of Medicine, Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts 02118., Wachman EM; Department of Pediatrics, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts 02118., Cruz-Martín A; Neurobiology Section, Department of Biology, Boston University, Boston, Massachusetts 02215., Bryant CD; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118 camron@bu.edu.
Publikováno v:
ENeuro [eNeuro] 2021 Sep 20; Vol. 8 (5). Date of Electronic Publication: 2021 Sep 20 (Print Publication: 2021).
Autor:
Yao EJ; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA., Babbs RK; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA., Luttik KP; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA., Borrelli KN; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA.; Graduate Program for Neuroscience, Boston University, Boston, Massachusetts, USA.; Tranformative Training Program in Addiction Science (TTPAS), Boston University, Boston, Massachusetts, USA.; Biomolecluar Pharmacology Training Program, Boston University School of Medicine, Boston, Massachusetts, USA., Damaj MI; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA., Mulligan MK; Department of Genetics, Genomics, and Informatics, The University of Tennessee Health Science Center, Memphis, Tennessee, USA., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA.; Graduate Program for Neuroscience, Boston University, Boston, Massachusetts, USA.; Tranformative Training Program in Addiction Science (TTPAS), Boston University, Boston, Massachusetts, USA.; Biomolecluar Pharmacology Training Program, Boston University School of Medicine, Boston, Massachusetts, USA.
Publikováno v:
Genes, brain, and behavior [Genes Brain Behav] 2021 May 12, pp. e12751. Date of Electronic Publication: 2021 May 12.
Autor:
Ribeiro, Gabriela1,2 (AUTHOR), Fernandes, Ana B.1,3 (AUTHOR), Oliveira, Francisco P. M.1 (AUTHOR), Duarte, João S.4 (AUTHOR), Oliveira, Manuela4 (AUTHOR), Limbert, Clotilde4 (AUTHOR), Costa, Rui M.5,6 (AUTHOR), Costa, Durval C.1 (AUTHOR), Oliveira-Maia, Albino J.1,3 (AUTHOR) albino.maia@neuro.fchampalimaud.org
Publikováno v:
PLoS Biology. 12/17/2024, Vol. 22 Issue 12, p1-23. 23p.
Autor:
Awad, Gaëlle1 (AUTHOR), Aubry, Anne-Sophie1 (AUTHOR), Olmstead, Mary C.2 (AUTHOR), Befort, Katia1 (AUTHOR) katia.befort@unistra.fr
Publikováno v:
Nutritional Neuroscience. Nov2024, Vol. 27 Issue 11, p1269-1282. 14p.
Autor:
Babbs RK; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA., Beierle JA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA; Biomolecular Pharmacology Ph.D. Program, Boston University School of Medicine, USA; Boston University's Transformative Training Program in Addiction Science (TTPAS), Biomedical Genetics, Boston University School of Medicine, 72 E. Concord St., E-200, Boston, MA, 02118, USA., Yao EJ; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA., Medeiros AR; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA; National Institute on Drug Abuse Diversity Scholars Program, 6001 Executive Boulevard, Room 3105, MSC 9567, Bethesda, MD, USA, 20892-9567., Anandakumar J; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA; National Institute on Drug Abuse Diversity Scholars Program, 6001 Executive Boulevard, Room 3105, MSC 9567, Bethesda, MD, USA, 20892-9567., Shah AA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA., Chen MM; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA., Johnson WE; Department of Medicine, Division of Computational Biomedicine, Boston University, 72 E. Concord St., E-609, Boston, MA, 02118, USA., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA, 02118, USA. Electronic address: camron@bu.edu.
Publikováno v:
Appetite [Appetite] 2020 Jul 01; Vol. 150, pp. 104678. Date of Electronic Publication: 2020 Mar 21.
Autor:
Babbs RK; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Beierle JA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.; T32 NIGMS Training Program in Biomolecular Pharmacology.; Boston University's Transformative Training Program in Addiction Science (TTPAS), Biomedical Genetics, Boston University School of Medicine, Boston, MA 02118., Ruan QT; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.; T32 NIGMS Training Program in Biomolecular Pharmacology.; Boston University's Transformative Training Program in Addiction Science (TTPAS), Biomedical Genetics, Boston University School of Medicine, Boston, MA 02118., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Chen MM; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Feng AX; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Kirkpatrick SL; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Benitez FA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Rodriguez FA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Pierre JJ; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Anandakumar J; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry., Kumar V; The Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609, and., Mulligan MK; Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, 71 S. Manassas St, Memphis, TN 38163., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry camron@bu.edu.
Publikováno v:
G3 (Bethesda, Md.) [G3 (Bethesda)] 2019 Sep 04; Vol. 9 (9), pp. 3009-3022. Date of Electronic Publication: 2019 Sep 04.
Autor:
Babbs RK; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, United States., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, United States., Scotellaro JL; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, United States; Boston University Undergraduate Research Opportunity Program (UROP), United States., Luttik KP; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, United States; Boston University Undergraduate Research Opportunity Program (UROP), United States., Mulligan MK; Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN 38163, United States., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, United States. Electronic address: camron@bu.edu.
Publikováno v:
Physiology & behavior [Physiol Behav] 2018 Dec 01; Vol. 197, pp. 51-66. Date of Electronic Publication: 2018 Sep 24.
Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.
Autor:
Goldberg LR; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.; Graduate Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, MA, USA., Kirkpatrick SL; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA., Yazdani N; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.; Graduate Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, MA, USA.; Transformative Training Program in Addiction Science, Boston University School of Medicine, Boston, MA, USA., Luttik KP; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA., Lacki OA; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA., Babbs RK; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA., Jenkins DF; Graduate Program in Bioinformatics, Boston University, Boston, MA, USA.; Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA., Johnson WE; Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.
Publikováno v:
Genes, brain, and behavior [Genes Brain Behav] 2017 Sep; Vol. 16 (7), pp. 725-738. Date of Electronic Publication: 2017 Jul 06.
Autor:
Veldhuizen MG; The John B. Pierce Laboratory, 290 Congress Avenue, New Haven, CT 06519, USA; Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA., Babbs RK; The John B. Pierce Laboratory, 290 Congress Avenue, New Haven, CT 06519, USA; Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA., Patel B; The John B. Pierce Laboratory, 290 Congress Avenue, New Haven, CT 06519, USA; Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA., Fobbs W; The John B. Pierce Laboratory, 290 Congress Avenue, New Haven, CT 06519, USA., Kroemer NB; The John B. Pierce Laboratory, 290 Congress Avenue, New Haven, CT 06519, USA; Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA; School of Psychology, University of Sussex, Falmer, Brighton BN1 9QH, UK., Garcia E; The John B. Pierce Laboratory, 290 Congress Avenue, New Haven, CT 06519, USA., Yeomans MR; Department of General Psychiatry and Psychotherapy, Calwerstrasse 14, University of Tübingen, 72076 Tübingen, Germany., Small DM; The John B. Pierce Laboratory, 290 Congress Avenue, New Haven, CT 06519, USA; Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA. Electronic address: dana.small@yale.edu.
Publikováno v:
Current biology : CB [Curr Biol] 2017 Aug 21; Vol. 27 (16), pp. 2476-2485.e6. Date of Electronic Publication: 2017 Aug 10.
Autor:
Kirkpatrick SL; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts., Goldberg LR; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts; Graduate Program in Biomolecular Pharmacology, Boston University, Boston, Massachusetts., Yazdani N; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts; Graduate Program in Biomolecular Pharmacology, Boston University, Boston, Massachusetts; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts., Babbs RK; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts., Wu J; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts; Ph.D. Program in Biomedical Sciences, Graduate Program in Genetics and Genomics, Boston University, Boston, Massachusetts; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts., Reed ER; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts; Ph.D. Program in Bioinformatics, Boston University, Boston, Massachusetts., Jenkins DF; Computational Biomedicine, Boston University, Boston, Massachusetts; Ph.D. Program in Bioinformatics, Boston University, Boston, Massachusetts., Bolgioni AF; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts; Graduate Program in Biomolecular Pharmacology, Boston University, Boston, Massachusetts., Landaverde KI; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts., Luttik KP; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts., Mitchell KS; Department of Psychiatry, Boston University School of Medicine, Boston University, Boston, Massachusetts., Kumar V; The Jackson Laboratory, Bar Harbor, Maine., Johnson WE; Computational Biomedicine, Boston University, Boston, Massachusetts., Mulligan MK; Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, Tennessee., Cottone P; Laboratory of Addictive Disorders, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts. Electronic address: camron@bu.edu.
Publikováno v:
Biological psychiatry [Biol Psychiatry] 2017 May 01; Vol. 81 (9), pp. 757-769. Date of Electronic Publication: 2016 Oct 25.